So Chi Wai, Karsunky Holger, Passegué Emmanuelle, Cozzio Antonio, Weissman Irving L, Cleary Michael L
Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Cancer Cell. 2003 Feb;3(2):161-71. doi: 10.1016/s1535-6108(03)00019-9.
A specific association with mixed lineage leukemias suggests that MLL oncoproteins may selectively target early multipotent hematopoietic progenitors or stem cells. We demonstrate here that a representative MLL fusion protein, MLL-GAS7, impairs the differentiation and enhances the in vitro growth of murine hematopoietic cells with multipotent features. The multilineage differentiation potential of these cells was suggested by their immuno-phenotypes and transcriptional programs and confirmed by their ability to induce three pathologically distinct leukemias in mice, including an acute biphenotypic leukemia (ABL) that recapitulates the distinctive hallmark features of many MLL-associated leukemias in humans. This experimental modeling of ABL in mice highlights its origin from multipotential progenitors that arrest at a bipotential stage specifically targeted or induced by MLL oncogenes.
与混合谱系白血病的特定关联表明,MLL癌蛋白可能选择性地靶向早期多能造血祖细胞或干细胞。我们在此证明,一种代表性的MLL融合蛋白MLL-GAS7损害了具有多能特征的小鼠造血细胞的分化,并增强了其体外生长。这些细胞的多谱系分化潜能通过其免疫表型和转录程序得以体现,并通过它们在小鼠中诱导三种病理上不同的白血病的能力得到证实,其中包括一种急性双表型白血病(ABL),它重现了人类许多与MLL相关白血病的独特标志性特征。小鼠中ABL的这种实验模型突出了其起源于多能祖细胞,这些祖细胞在一个由MLL癌基因特异性靶向或诱导的双能阶段停滞。